Ventana Biotech, Inc. (VNTA)
- Previous Close
0.0030 - Open
0.0031 - Bid --
- Ask --
- Day's Range
0.0030 - 0.0030 - 52 Week Range
0.0004 - 0.0050 - Volume
20,000 - Avg. Volume
8,453 - Market Cap (intraday)
3.227M - Beta (5Y Monthly) -2.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0010 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.
Related News
Performance Overview: VNTA
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VNTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VNTA
Valuation Measures
Market Cap
3.23M
Enterprise Value
3.23M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-47.08k
Diluted EPS (ttm)
-0.0010
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: VNTA
VNTA does not have Company Insights